Highlights and Quick Summary
- Annual Cash ROIC for 2022 was -28.23% (a 194.68% increase from previous year)
- Annual Cash ROIC for 2021 was -9.58% (a 35.5% increase from previous year)
- Annual Cash ROIC for 2020 was -7.07% (a -Infinity% decrease from previous year)
- Twelve month Cash ROIC ending September 30, 2023 was -40.46% (a 33.71% increase compared to previous quarter)
- Twelve month trailing Cash ROIC increased by 96.12% year-over-year
Trailing Cash ROIC for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| -40.46% | -30.26% | -22.12% | -20.63% |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash ROIC of Prime Medicine, Inc.
Most recent Cash ROICof PRME including historical data for past 10 years.Interactive Chart of Cash ROIC of Prime Medicine, Inc.
Prime Medicine, Inc. Cash ROIC for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -28.23% |
| 2021 | – | – | – | – | -9.58% |
| 2020 | – | – | – | – | -7.07% |
| 2019 | – | – | – | – | 0.0% |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology